Government Relations

Drug Shortages

Drug Shortages

From time to time, the nuclear medicine and molecular imaging community faces isotope shortages due to a variety of reasons. SNMMI strives to serve as a resource for its members, industry, government and the media. Information regarding production delays and current shortages can be found below.

Status Update on NTP's Radiochemical Production Facility (December 2, 2013) 

Update on Mo-99 Availability (November 21, 2013)

Mallinckrodt Releases Letter Updating the Mo-99 Supply Outlook (November 20, 2013)

Mallinckrodt Releases Letter Updating the Mo-99 Supply Outlook (November 15, 2013)

Update Regarding Shortage of DRAXIMAGE® MAA Kits (October 31, 2013)

Update Regarding Shortage of DRAXIMAGE® MAA Kits (October 11, 2013)

Prescriber Beware: It Is Ill Advised to Administer Compounded Sincalide (October 9, 2013)

Update Regarding Shortage of DRAXIMAGE® MAA Kits (September 20, 2013)

DRAXIMAGE® Announces MAA Kits Unavailable Until Mid-October (September 13, 2013)

SNMMI Statement (September 17, 2013)

Sincalide is Temporarily Unavailable—Again (July 31, 2013)

NRG customer letter on HFR status (April 16, 2013)

Mallincrodt Provides Additional Update on Dutch High-Flux Reactor (April 12, 2013)

NRG customer letter on HFR status (April 3, 2013)

Mallincrodt Provides Additional Update on Dutch High-Flux Reactor (March 22, 2013)

Mallincrodt Provides Additional Update on Dutch High-Flux Reactor (February 28, 2013)

Mallincrodt Provides Additional Update on Dutch High-Flux Reactor (January 30, 2013)

Mallincrodt Provides Additional Update on Dutch High-Flux Reactor (January 9, 2013)

Mallinckrodt Provides Additional Update on Dutch High-Flux Reactor (December 21, 2012)

Mallinckrodt Provides Update on Dutch High-Flux Reactor (November 30, 2012)

Related Items